Attovia Therapeutics Inc（ATTO）价格预测ATTOAttovia Therapeutics Inc

Attovia Therapeutics is not a good buy right now due to its current price of $13.73, which is significantly below the lowest analyst price target of $30, indicating potential upside. However, the stock has a very low RSI of 16.74, suggesting it is oversold, but the negative momentum and substantial losses in recent quarters raise concerns. The company reported a net loss of $20.69 million in Q2 2026, which is a risk to consider.

Attovia Therapeutics Inc (ATTO) last closed at $14.18, gaining +1.00%. These facts feed the 1-day and 1-week ATTO price prediction above.